Top ▲
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Not curated in GtoImmuPdb
Target id: 2363
Nomenclature: coagulation factor VII
Family: S1: Chymotrypsin
Annotation status:
Annotated and awaiting review
» Email us
Gene and Protein Information ![]() |
||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 466 | 13q34 | F7 | coagulation factor VII | |
Mouse | - | 446 | 8 5.73 cM | F7 | coagulation factor VII | |
Rat | - | 446 | 16q12.5 | F7 | coagulation factor VII |
Previous and Unofficial Names ![]() |
factor VII | Cf7 | eptacog alfa | FVII | serum prothrombin conversion accelerator | coagulation factor VII (serum prothrombin conversion accelerator) |
Database Links ![]() |
|
Specialist databases | |
MEROPS | S01.215 (Hs) |
Other databases | |
Alphafold | P08709 (Hs), P70375 (Mm), Q8K3U6 (Rn) |
BRENDA | 3.4.21.21 |
CATH/Gene3D | 4.10.740.10 |
ChEMBL Target | CHEMBL3991 (Hs) |
DrugBank Target | P08709 (Hs) |
Ensembl Gene | ENSG00000057593 (Hs), ENSMUSG00000031443 (Mm), ENSRNOG00000032737 (Rn) |
Entrez Gene | 2155 (Hs), 14068 (Mm), 260320 (Rn) |
Human Protein Atlas | ENSG00000057593 (Hs) |
KEGG Enzyme | 3.4.21.21 |
KEGG Gene | hsa:2155 (Hs), mmu:14068 (Mm), rno:260320 (Rn) |
OMIM | 613878 (Hs) |
Orphanet | ORPHA121675 (Hs) |
Pharos | P08709 (Hs) |
RefSeq Nucleotide | NM_000131 (Hs), NM_019616 (Hs), NM_010172 (Mm), NM_152846 (Rn) |
RefSeq Protein | NP_000122 (Hs), NP_062562 (Hs), NP_034302 (Mm), NP_690059 (Rn) |
UniProtKB | P08709 (Hs), P70375 (Mm), Q8K3U6 (Rn) |
Wikipedia | F7 (Hs) |
Enzyme Reaction ![]() |
||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Clinically-Relevant Mutations and Pathophysiology ![]() |
||||||||||||
|
1. Dickman DA, Kumar DV, O'bryan C, Rai R, Shrader WD, Wesson K. (2005) Factor viia inhibitor. Patent number: WO2005118554A2. Assignee: Pharmacyclics, Inc.. Priority date: 02/06/2004. Publication date: 15/12/2005.
2. Vijaykumar D, Rai R, Shaghafi M, Ton T, Torkelson S, Leahy EM, Riggs JR, Hu H, Sprengeler PA, Shrader WD et al.. (2006) Efforts toward oral bioavailability in factor VIIa inhibitors. Bioorg Med Chem Lett, 16 (14): 3829-32. [PMID:16650987]
3. Young WB, Rai R, Shrader WD, Burgess-Henry J, Hu H, Elrod KC, Sprengeler PA, Katz BA, Sukbuntherng J, Mordenti J. (2006) Small molecule inhibitors of plasma kallikrein. Bioorg Med Chem Lett, 16 (7): 2034-6. [PMID:16413183]
Last modified on 11/01/2023.
The citation format for the published version of this page will be:
S1: Chymotrypsin: coagulation factor VII. Last modified on 11/01/2023. Accessed on 12/09/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2363.